Bilaketaren emaitzak - Chandhasin, Chandtip

Subtle Mutational Changes in the SU Protein of a Natural Feline Leukemia Virus Subgroup A Isolate Alter Disease Spectrum nork Chandhasin, Chandtip, Coan, Patricia N., Levy, Laura S.

Testu osoa Testu osoa Testu osoa

NIMG-28. VALIDATION OF MODIFIED RESPONSE ASSESSMENT IN NEURO ONCOLOGY (mRANO) DETERMINED PFS AS A STRONG PREDICTOR OF OVERALL SURVIVAL IN RECURRENT GLIOBLASTOMA TREATED WITH A TARG... nork Ellingson, Benjamin, Chandhasin, Chandtip, Coello, Melissa, Merchant, Nina, Merchant, Fahar

Testu osoa Testu osoa

Human T-Cell Leukemia Virus Type 1 Tax Attenuates the ATM-Mediated Cellular DNA Damage Response nork Chandhasin, Chandtip, Ducu, Razvan I., Berkovich, Elijahu, Kastan, Michael B., Marriott, Susan J.

Testu osoa Testu osoa Testu osoa

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer nork Antonarakis, Emmanuel S., Chandhasin, Chandtip, Osbourne, Erica, Luo, Jun, Sadar, Marianne D., Perabo, Frank

Testu osoa Testu osoa Testu osoa

Distinctive receptor binding properties of the surface glycoprotein of a natural Feline Leukemia Virus isolate with unusual disease spectrum nork Bolin, Lisa L, Chandhasin, Chandtip, Lobelle-Rich, Patricia A, Albritton, Lorraine M, Levy, Laura S

Testu osoa Testu osoa Testu osoa

Unique Long Terminal Repeat and Surface Glycoprotein Gene Sequences of Feline Leukemia Virus as Determinants of Disease Outcome nork Chandhasin, Chandtip, Coan, Patricia N., Pandrea, Ivona, Grant, Chris K., Lobelle-Rich, Patricia A., Puetter, Adriane, Levy, Laura S.

Testu osoa Testu osoa Testu osoa

CLRM-09. INCORPORATING EXTERNAL CONTROL ARM IN MDNA55 RECURRENT GLIOBLASTOMA REGISTRATION TRIAL nork Davi, Ruthanna, Majumdar, Antara, Bexon, Martin, Butowski, Nicholas, Chandhasin, Chandtip, Coello, Melissa, Das, Sunit, Merchant, Fahar, Merchant, Nina, Reardon, David, Roessner, Martin, Sampson, John

Testu osoa Testu osoa

Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer nork Naing, Aung, Kurzrock, Razelle, Burger, Angelika, Gupta, Sachin, Lei, Xiudong, Busaidy, Naifa, Hong, David, Chen, Helen X., Doyle, Lawrence A., Heilbrun, Lance K., Rohren, Eric, Ng, Chaan, Chandhasin, Chandtip, LoRusso, Patricia

Testu osoa Testu osoa Testu osoa

ATIM-30. COMBATING RECURRENT GLIOBLASTOMA WITH MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, THROUGH MRI-GUIDED CONVECTIVE DELIVERY nork Sampson, John, Singh Achrol, Achal, Aghi, Manish, Bankiewicz, Krystof, Brem, Steven, Brenner, Andrew, Butowski, Nicholas, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Floyd, John R, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Bexon, Martin

Testu osoa Testu osoa

CTIM-13. CLINICAL EFFICACY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, IN RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) nork Sampson, John, Achrol, Achal, Aghi, Manish, Bankiewiecz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin, Floyd, John, Han, Seunggu, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas

Testu osoa Testu osoa

CTIM-28. MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, FOR RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) nork Sampson, John, Achrol, Achal Singh, Aghi, Manish K, Bankiewiecz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin, Floyd, John, Han, Seunggu, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas

Testu osoa Testu osoa